MBX Biosciences, Inc. ($MBX)
Filing Information
| Accession Number | 0001193125-26-216704 |
|---|---|
| Form Type | 4 |
| Filing Date | May 11, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
210,009
Total Value
$3,500,862.90
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | May 8, 2026 | Exercise/Conversion | 55,000 | $10.46 | $575,300.00 | 69,769 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | May 8, 2026 | Sale | 55,000 | $38.38 | $2,110,900.00 | 14,769 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | May 8, 2026 | Exercise/Conversion | 15,003 | $16.00 | $240,048.00 | 29,772 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | May 8, 2026 | Sale | 15,003 | $38.30 | $574,614.90 | 14,769 | Direct | โ | View Details | |
Chief Medical Officer | Stock option (right to buy) | Derivative | May 8, 2026 | Exercise/Conversion | 55,000 | $0.00 | $0.00 | 194,540 | Direct | โ | View Details | |
Chief Medical Officer | Stock option (right to buy) | Derivative | May 8, 2026 | Exercise/Conversion | 15,003 | $0.00 | $0.00 | 30,008 | Direct | โ | View Details |